Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 03-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 172 | N/A |
| Other current assets | 0 | 0 | 0 | 326 | 200 |
| TOTAL | $0 | $0 | $0 | $497 | $200 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 120 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $120 |
| Total Assets | $0 | $0 | $0 | $509 | $320 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,225 | 730 |
| Accrued Expenses | 0 | 0 | 0 | 1,665 | 570 |
| Other current liabilities | 0 | 0 | 0 | 3,258 | 130 |
| TOTAL | $0 | $0 | $0 | $6,148 | $3,890 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 11,919 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $11,919 | $570 |
| Total Liabilities | $0 | $0 | $0 | $18,066 | $4,460 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 0 | 5 | 120 |
| Retained earnings | 0 | 0 | 0 | -21,602 | N/A |
| Other shareholders' equity | 0 | 0 | 0 | 2 | 0 |
| TOTAL | $0 | $0 | $0 | $-17,557 | $45,880 |
| Total Liabilities And Equity | $0 | $0 | $0 | $509 | $50,340 |